On the contrary, HIF-1A targets resulted upregulated in HCC (even though not statistically significant for GLUT1) but showed no significant associations with clinicopathological features except for high ALDOA expression in patients with MVI (Fig. S2F-L). The gene discussed is SLC2A1; the disease is hepatocellular carcinoma.